Skip to Content

Erythromycin Lactobionate Injection

Last Updated: February 12, 2018
Status: Resolved

Erythromycin Lactobionate Injection

Products Affected - Description
  • Erythrocin powder for solution for injection, Pfizer
    500 mg, ADD-Vantage vial, 10 count (NDC 00409-6476-44)

500 mg, vial, 10 count (NDC 00409-6482-01)
Reason for the Shortage
  • Pfizer has Erythrocin on shortage due to manufacturing delays.

Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

  • Pfizer has Erythrocin 500 mg ADD-Vantage vials on back order and the company estimates a release date of March 2018. The Erythrocin 500 mg regular vials are on back order and the company estimates a release date of September 2018.

Updated

February 12, January 29, 2018; November 10, October 30 and 2, August 7, July 14 and 10, May 22, April 30 and 18, March 22, January 30, 2017; November 21, October 31, September 22, August 29, 10 and 5, July 11, 2016, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide